In the BioHarmony Drug Report Database
Lexapro (escitalopram) is a small molecule pharmaceutical. Escitalopram was first approved as Lexapro on 2002-08-14. It is used to treat major depressive disorder in the USA. The pharmaceutical is active against sodium-dependent serotonin transporter. Lexapro’s patent is valid until 2022-08-12 (FDA).
Image (chem structure or protein)